Skip to content
10-Q

Quarterly Report

MIRATI THERAPEUTICS, INC.

0001628280-23-036875

← back to feed
Filed
Nov 6, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 1, 2023 70.15M sh
Shares Diluted Q3 2023 · Sep 30, 2023 64.99M sh
Shares Diluted Q3 2023 · Sep 30, 2023 60.42M sh
Shares Diluted Q3 2023 · Sep 30, 2022 56.22M sh
Shares Diluted Q3 2023 · Sep 30, 2022 55.75M sh
Capex Q3 2023 · Sep 30, 2023 $1.03M
Capex Q3 2023 · Sep 30, 2022 $4.04M
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$465.3M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$441.77M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $258.72M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $235.26M
Cash And Equivalents Q3 2023 · Sep 30, 2022 $298.84M
Stockholders Equity Q3 2023 · Sep 30, 2023 $946.47M
Stockholders Equity Q3 2023 · Jun 30, 2023 $728.95M
Stockholders Equity Q3 2023 · Dec 31, 2022 $996.52M
Stockholders Equity Q3 2023 · Sep 30, 2022 $1.13B
Stockholders Equity Q3 2023 · Jun 30, 2022 $1.11B
Stockholders Equity Q3 2023 · Dec 31, 2021 $1.4B
Current Liabilities Q3 2023 · Sep 30, 2023 $137.38M
Current Liabilities Q3 2023 · Dec 31, 2022 $159.45M
Total Liabilities Q3 2023 · Sep 30, 2023 $183.24M
Total Liabilities Q3 2023 · Dec 31, 2022 $206.13M
Current Assets Q3 2023 · Sep 30, 2023 $1.04B
Current Assets Q3 2023 · Dec 31, 2022 $1.11B
Total Assets Q3 2023 · Sep 30, 2023 $1.13B
Total Assets Q3 2023 · Dec 31, 2022 $1.2B
Eps Diluted Q3 2023 · Sep 30, 2023 −$2.49
Eps Diluted Q3 2023 · Sep 30, 2023 −$8.66
Eps Diluted Q3 2023 · Sep 30, 2022 −$3.09
Eps Diluted Q3 2023 · Sep 30, 2022 −$9.66
Eps Basic Q3 2023 · Sep 30, 2023 −$2.49
Eps Basic Q3 2023 · Sep 30, 2023 −$8.66
Eps Basic Q3 2023 · Sep 30, 2022 −$3.09
Eps Basic Q3 2023 · Sep 30, 2022 −$9.66
Sga Expense Q3 2023 · Sep 30, 2023 $72M
Sga Expense Q3 2023 · Sep 30, 2023 $220.98M
Sga Expense Q3 2023 · Sep 30, 2022 $60.8M
Sga Expense Q3 2023 · Sep 30, 2022 $168.98M
Rd Expense Q3 2023 · Sep 30, 2023 $114.77M
Rd Expense Q3 2023 · Sep 30, 2023 $365.64M
Rd Expense Q3 2023 · Sep 30, 2022 $131.08M
Rd Expense Q3 2023 · Sep 30, 2022 $390.39M
Net Income Q3 2023 · Sep 30, 2023 −$161.9M
Net Income Q3 2023 · Sep 30, 2023 −$523.4M
Net Income Q3 2023 · Sep 30, 2022 −$173.56M
Net Income Q3 2023 · Sep 30, 2022 −$538.39M
Operating Income Q3 2023 · Sep 30, 2023 −$172.05M
Operating Income Q3 2023 · Sep 30, 2023 −$553.15M
Operating Income Q3 2023 · Sep 30, 2022 −$186.44M
Operating Income Q3 2023 · Sep 30, 2022 −$547.87M
Revenue Q3 2023 · Sep 30, 2023 $16.4M
Revenue Q3 2023 · Sep 30, 2023 $37.26M
Revenue Q3 2023 · Sep 30, 2022 $5.43M
Revenue Q3 2023 · Sep 30, 2022 $11.5M